EyeSense is developing a continuous blood glucose monitoring system (CGM), FiberSense, with the aim of improving the standard of care for diabetics. The Company’s system utilizes innovative technologies that differentiate it from other CGM devices, particularly by improving measurement accuracy, increasing usage time prior to replacement and reducing cost.